Kempharm - Prakiraan wutah bathi resik saben saham kanggo taun ngarep ZVRA

Logo korporat perusahaan Zevra Therapeutics (ZVRA)

Zevra Therapeutics (ZVRA) is establishing a comprehensive environment for the therapy of rare neurological pathologies. Reviewing the history of forward earnings per share valuations on GURU.Markets, we see that -28.90 determines the latest valuation metric. Zevra Therapeutics relies on a proprietary drug development base for niche CNS markets, possessing significant pricing power. Current sales of approved products generate operational liquidity, stabilizing cash flows.

Kempharm (ZVRA): Prakiraan wutah bathi resik saben saham kanggo taun ngarep saka 28.04.2023 nganti 17.11.2026

Ringkesan rincian data analitis Kempharm (ZVRA)

Analisis fundamental perusahaan:Kempharm
Produk dadi Zevra Therapeutics Inc

This indicator reflects the analysts' consensus forecast for the growth rate of earnings per share (EPS) for the coming year. It measures the dynamics of market expectation revisions, where the trend of EPS growth forecasts serves as a filter for market noise. A steady upward curve confirms the fundamental resilience of the business. For Zevra Therapeutics (ZVRA), this is critical: the scalability of orphan drugs allows the company to convert prescription growth into a high-margin cash flow.

Karo sapa Zevra Therapeutics saingan

Prakiraan wutah bathi resik saben saham kanggo taun ngarep Jazz Pharmaceuticals|CYTK: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep PTC Bio (PTCT)|SRRK - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Centessa Pharmaceuticals PLC CNTA|Dyne Pharma (DYN) - Prakiraan wutah bathi resik saben saham ing taun ngarep|EWTX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Rapport Therapeutics, Inc.|ALMS: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Contineum Pharma CTNM|Prakiraan wutah bathi saben saham kanggo taun ngarep LRMR|Prakiraan wutah bathi resik saben saham ing taun ngarep Capricor Therapeutics CAPR|Prakiraan wutah bathi kanggo taun ngarep TRDA|Prakiraan wutah bathi saben saham kanggo taun ngarep Channel Therapeutics PTHS|Prakiraan wutah bathi kanggo taun ngarep MNOV (MediciNova)|Dinamika bathi saben saham sing diarepake ing taun ngarep SER|BTAI - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|promisneurosciences.com (PMN) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Apimeds (APUS) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep AEON|Prakiraan wutah bathi resik saben saham kanggo taun ngarep NLS Pharma|Prakiraan wutah bathi resik saben saham ing taun ngarep bionomics.com.au BNOX|Prakiraan wutah bathi kanggo taun ngarep HUGE|RETA (Reata Pharma) - Dinamika bathi saben saham sing diarepake ing taun ngarep